Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Biotechnology

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd

Bullboard Posts

Post by MakingHayon Mar 04, 2018 7:39am

251 Views

Post# 27657613

LBL Share holders were never informed

of change in focus of business direction by LBL management. This info was only released after a five month news blackout and management was forced to surface and satisify the BCSC with a LBL management cease trade order "MCTO" Otherwise, i'm sure a general company cease trade order was coming down the tube from the BCSC.

What is the matter with LBL management? Why the silence? Why do they keep share holders uninformed???
Why did'nt management inform share holders at a much earlier date they were changing it's business focus from sports injury to the personal injury market. Or, is the personal injury market an add on bonus to the LBL sports injury market?

So many questions with a management that refuses to answer to shareholders. At least for the last seven months anyway. Until things change, LBL is just a casino play. So sad ................. Hay

Bullboard Posts

Nextech CEO provides company update on Amazon deal and more